Shanghai Hile Bio shareholder completes 2% stake reduction

Shanghai Hile Bio-Technology (SSE:603718) announced that shareholder Fang Zhangle has completed their previously disclosed plan to reduce their stake in the company. Between April 15, 2025, and April 22, 2025, Fang Zhangle sold 13,113,244 shares via block trades, representing 2% of the company's total share capital. The shares were sold at prices ranging from CNY6.93 to CNY7.16, resulting in a total transaction value of CNY92,781,848.92. Following the completion of this share reduction, Fang Zhangle now holds 16,320,107 shares of Shanghai Hile Bio, representing 2.49% of the company's total shares. Fang Zhangle's associate, Fang Wenyan, holds 4.12% of shares.